Shunsuke Kimura,Chun Shik Park,Lindsey E. Montefiori,Ilaria Iacobucci,Petri Pölönen,Qingsong Gao,Elizabeth D. Arnold,Andishe Attarbaschi,Anthony Brown,Barbara Buldini,Kenneth J. Caldwell,Yunchao Chang,Chelsey Chen,Cheng,Zhongshan Cheng,John Choi,Valentino Conter,Kristine R. Crews,Hester A. de Groot-Kruseman,Takao Deguchi,Mariko Eguchi,Hannah E. Muhle,Sarah Elitzur,Gabriele Escherich,Burgess B. Freeman,Zhaohui Gu,Katie Han,Keizo Horibe,Toshihiko Imamura,Sima Jeha,Motohiro Kato,Kean H. Chiew,Tanya Khan,Michal Kicinski,Stefan Köhrer,Steven M. Kornblau,Rishi S. Kotecha,Chi-Kong Li,Yen-Chun Liu,Franco Locatelli,Selina M. Luger,Elisabeth M. Paietta,Atsushi Manabe,Hanne V. Marquart,Riccardo Masetti,Mellissa Maybury,Pauline Mazilier,Jules P.P. Meijerink,Sharnise Mitchell,Takako Miyamura,Andrew S. Moore,Koichi Oshima,Katarzyna Pawinska-Wasikowska,Rob Pieters,Mollie S. Prater,Shondra M. Pruett-Miller,Ching-Hon Pui,Chunxu Qu,Michaela Reiterova,Noemi Reyes,Kathryn G. Roberts,Jacob M. Rowe,Atsushi Sato,Kjeld Schmiegelow,Martin Schrappe,Shuhong Shen,Szymon Skoczeń,Orietta Spinelli,Jan Stary,Michael Svaton,Masatoshi Takagi,Junko Takita,Yanjing Tang,David T. Teachey,Paul G. Thomas,Daisuke Tomizawa,Jan Trka,Elena Varotto,Tiffaney L. Vincent,Jun J. Yang,Allen E.J. Yeoh,Yinmei Zhou,Martin Zimmermann,Hiroto Inaba,Charles G. Mullighan

Supplementary Table 3 from NSD2 Is Recruited through Its PHD Domain to Oncogenic Gene Loci to Drive Multiple Myeloma

Supplementary Table 2 from NSD2 Is Recruited through Its PHD Domain to Oncogenic Gene Loci to Drive Multiple Myeloma

Supplementary Figure from NSD2 is Recruited Through Its PHD Domain to Oncogenic Gene Loci to Drive Multiple Myeloma

Supplementary Table 3 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Supplemental Table S1 from PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 4 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 2 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 1 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 6 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 5 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of T(4;14)-Positive Multiple Myeloma

Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table S5 from CD38-Mediated Immunosuppression As a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Supplementary Figure S6 G-K from Drugging MYCN Oncogenic Signaling Through the MYCN-PA2G4 Binding Interface

Supplementary Table S17 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements As Extremely High Risk

Supplementary Table S24 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements As Extremely High Risk

Supplementary Table 15 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Supplementary Tables 1-5 from Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid Sarcoma